Immune checkpoint blockade (ICB) has revolutionized cancer treatment. However, ICB alone has demonstrated only benefit in a small subset of patients with breast cancer. We here reported that the tumor

NIAID Data Ecosystem30

Table_1_PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma.xlsx

癌症分子分型

肿瘤治疗响应

BackgroundHepatocellular carcinoma (HCC) is a highly prevalent and fatal cancer. The role of PANoptosis, a novel form of programmed cell death, in HCC is yet to be fully understood. This study focuses

NIAID Data Ecosystem20

Patient demographics.

腹膜间皮瘤治疗

化疗疗效

Background Diffuse malignant peritoneal mesothelioma (DMPM) is a rare variant of malignant mesothelioma, representing 10–15% of malignant mesothelioma cases. The preferred therapeutic approach is cyto

NIAID Data Ecosystem60

Tumour growth responses to therapy.

肿瘤治疗响应

肿瘤生长监测

Tumour growth responses to therapy.

Figshare2017-06-30 更新20